AkzoNobel publishes Q1 2014 results Volume and

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
AkzoNobel publishes Q1 2014 results
  • Volume and price/mix development positive in all three Business Areas
  • Revenue down 2 percent due to 5 percent currency effects
  • Restructuring costs of €44 million (2013 €29 million). Excluding these, ROS% is 7.7 percent (2013: 7.1 percent)
  • Operating income at €216 million (2013: €217 million) reflects adverse currencies and €15 million higher restructuring costs
  • Net income attributable to shareholders at €129 million increased (2013: €89 million) mainly due to lower financing expenses
  • Adjusted EPS at €0.61 (2013: €0.51)
  • Net cash outflow from operating activities was €552 million (2013: €406 million)
  • On track to deliver 2015 targets despite expected continued fragile economic environment and volatile currencies in 2014

AMSTERDAM, Netherlands, April 17, 2014 (GLOBE NEWSWIRE) --

Q1 2014 in € million

  Q1 2013 Q1 2014 D%
Revenue 3,465 3,383 (2)
Operating income 217 216 -
Return on sales (ROS) % 6.3 6.4  
EBITDA 375 364 (3)
Net income attributable to shareholders 89 129 45

Akzo Nobel N.V. (AkzoNobel) today reported a positive volume and price/mix development in all three Business Areas. First quarter revenues of €3,383 million were 2 percent lower compared with the same period last year. The decrease was mainly a consequence of a 5 percent impact from currency translation. Operating income was flat at €216 million after €15 million higher restructuring charges and currencies. As a consequence of de-risking our pension liabilities in the UK, other comprehensive income in shareholders' equity was adversely affected by €0.8 billion. Continuous improvement programs are ongoing and the company is on track to achieve its 2015 targets.

CFO Keith Nichols

"These results are a further step towards the delivery of AkzoNobel's 2015 targets. Despite higher restructuring charges, continued adverse currency effects and ongoing weakness in Europe, our year-on-year return on sales, both before and after higher restructuring charges, improved for the third consecutive quarter. Net income attributable to shareholders and adjusted EPS have both increased significantly, benefiting from lower financing costs as a result of recent debt repayments. AkzoNobel remains on track to deliver its 2015 targets of 9 percent return on sales, 14 percent return on invested capital and a net debt/EBITDA ratio lower than 2.0."

Volume in Decorative Paints was up compared with 2013 due to development in Asia, while conditions in Europe and Latin America were challenging. Price/mix development was positive in all three regions. Revenue in Decorative Paints declined 6 percent due to 6 percent adverse currency effects, mainly in Latin America and Asia, and a 4 percent divestment effect from the sale of Building Adhesives. Operating income for the quarter was lower than the previous year, mainly due to higher restructuring costs in mature markets.

Volume in Performance Coatings was up 3 percent on 2013. Compared to the previous year, positive volume and price/mix development was more than offset due to a 6 percent negative impact from currencies. As a result, revenue declined 1 percent compared with 2013. Operating income was down 2 percent due to higher restructuring costs and currency translation.

Volume in Specialty Chemicals was higher compared with 2013 as a result of better market conditions in Functional Chemicals and the absence of the previous year's production issues, notably in Industrial Chemicals. Revenue declined due to adverse currency developments and divestments. Operating income was up 36 percent at €135 million due to cost control and operational efficiencies.

Outlook    
                                                                                

AkzoNobel is on track to deliver its 2015 targets despite the expected continued fragile economic environment and continued volatile currencies in 2014.

Business Area highlights

Decorative Paints    
Q1 2014 in €m    
  2013 2014 D%  
Revenue 925 865 (6)  
OPI 43 17 (60)  
ROS (in %) 4.6 2.0    
                 
Performance Coatings    
Q1 2014 in €m    
  2013 2014 D%  
Revenue 1,331 1,319 (1)  
OPI 129 126 (2)  
ROS (in %) 9.7 9.6    
                 
Specialty Chemicals    
Q1 2014 in €m    
  2013 2014 D%  
Revenue 1,244 1,222 (2)  
OPI 99 135 36  
ROS (in %) 8.0 11.0    
                 

The Q1 2014 report can be downloaded via the AkzoNobel Report iPad app http://bit.ly/obljrf or read online at www.akzonobel.com/quarterlyresults .

- - -
AkzoNobel is a leading global paints and coatings company and a major producer of specialty chemicals. We supply industries and consumers worldwide with innovative products and are passionate about developing sustainable answers for our customers. Our portfolio includes well-known brands such as Dulux, Sikkens, International and Eka. Headquartered in Amsterdam, the Netherlands, we are consistently ranked as one of the leaders in the area of sustainability. With operations in more than 80 countries, our 50,000 people around the world are committed to delivering leading products and technologies to meet the growing demands of our fast-changing world.

Not for publication - for more information

Corporate Media Relations, tel.: +31 20 502 7833 Corporate Investor Relations, tel.:+31 20 502 7854
Contact: Diana Abrahams Contact: Sheryl Stokes

Safe Harbor Statement

This press release contains statements which address such key issues as AkzoNobel's growth strategy, future financial results, market positions, product development, products in the pipeline, and product approvals. Such statements should be carefully considered, and it should be understood that many factors could cause forecasted and actual results to differ from these statements. These factors include, but are not limited to, price fluctuations, currency fluctuations, developments in raw material and personnel costs, pensions, physical and environmental risks, legal issues, and legislative, fiscal, and other regulatory measures. Stated competitive positions are based on management estimates supported by information provided by specialized external agencies. For a more comprehensive discussion of the risk factors affecting our business please see our latest Annual Report, a copy of which can be found on the company's corporate website www.akzonobel.com .

AkzoNobel Press Release Q1 2014 http://hugin.info/130660/R/1778003/607148.pdf
AkzoNobel Report Q1 2014 http://hugin.info/130660/R/1778003/607150.pdf

HUG#1778003

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 302

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 377

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 180

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 464

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 322

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 360

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 405

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Fibocom Unveils U6G Solutions Advancing Global 5G Tech

Updated Category News Views 80

Breaking Barriers with U6G-Capable Technology Sneaking into the industry's spotlight at MWC Doha 2026, Fibocom flaunts a robust lineup of next-gen 5G solutions. It's as if they're shuffling every card they’ve got to win over the broadband world. With breakthroughs like the FG390, FG370, and FG670 modules, alongside PCBA-level innovations, Fibocom is not just throwing...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 182

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 146

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading

Top 5 Most Recently Viewed Articles

Prodigy Processing Solutions Leads the Charge in Cannabis Extraction

Updated Category News Views 240

Prodigy Processing Solutions Steps into New York's Cannabis Scene Prodigy Processing Solutions is making strides in the cannabis industry by teaming up with ProXtracts Processing Inc., a leading cannabis oil producer, to initiate a pioneering hydrocarbon extraction lab. This collaboration highlights Prodigy's commitment to providing top-notch extraction technologies while...

Continue Reading
Key Details for Moderna Investors Regarding Class Action

Updated Category News Views 69

Important Information for Moderna, Inc. Investors The Gross Law Firm has an important update for shareholders of Moderna, Inc. (NASDAQ: MRNA). If you've purchased shares during the specific class period, you're encouraged to reach out to the firm about possibly serving as lead plaintiffs in an upcoming class action lawsuit. Class Period and Lead Plaintiff Information If...

Continue Reading
Vistagen Therapeutics Investors: Important Legal Update Ahead

Updated Category News Views 117

Vistagen Therapeutics' Legal Challenges: A Summary for Investors As a prominent player in the therapeutic landscape, Vistagen Therapeutics, Inc. (NASDAQ: VTGN) is currently navigating significant legal challenges that investors should be aware of. Legal representation is crucial for those who have invested in the company's stock, particularly following the announcement of...

Continue Reading
Nilfisk Holding A/S Unveils Key 2025 Financial Dates

Updated Category News Views 494

Nilfisk Holding A/S Financial Calendar for 2025 Nilfisk Holding A/S stands out as a prominent global player in the professional cleaning industry, consistently delivering high-quality products and services. As the new year approaches, the company has set forth significant dates for financial disclosures that are vital for investors and stakeholders alike. Upcoming Key...

Continue Reading
Exciting Return of Twang’s Signature Beer and Pickle Salts

Updated Category News Views 332

Exciting Announcement from Twang Twang, a beloved Latino-founded brand, has once again captured the hearts of flavor enthusiasts. Known for its innovative and enticing blends of flavored salts, Twang is thrilled to share the return of two highly anticipated products: Orange Beer Salt and Hot Pickle Flavored Salt. Fans of these tasty seasonings can look forward to their...

Continue Reading